Neonatal Clinical Pharmacology-Reference-Cited by-同舟云学术

Neonatal Clinical Pharmacology

Published:2024-09-09 Issue:9 Volume:11 Page:1102
ISSN:2227-9067
Container-title:Children
language:en
Short-container-title:Children

Author:

Allegaert Karel¹²³^ORCID,Yalcin Nadir⁴,Flint Robert B.³⁵⁶^ORCID,Simons Sinno H. P.⁶^ORCID

Affiliation:

1. Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium

2. Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium

3. Department of Hospital Pharmacy, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands

4. Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara 06100, Türkiye

5. Rotterdam Clinical Pharmacometrics Group, Erasmus University Medical Centre, 3015 GD Rotterdam, The Netherlands

6. Department of Paediatric and Neonatal Intensive Care, Division of Neonatology, Erasmus University Medical Centre-Sophia Children’s Hospital, 3015 GD Rotterdam, The Netherlands

Abstract

Similar to other populations, care of neonates strongly relies on robust guidance on neonatal pharmacotherapy, covering an age-appropriate drug formulation, an individualized dose, and information on its efficacy and safety for a specific indication in this population, preferably weighted to alternative approaches [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2227-9067/11/9/1102/pdf

Reference3 articles.

1. Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates;Ward;Pediatr. Res.,2017

2. Shaniv, D., Bolisetty, S., Young, T.E., Mangum, B., Ainsworth, S., Elbers, L., Schultz, P., Cucchi, M., de Wildt, S.N., and van der Zanden, T.M. (2023). Neonatal Drug Formularies—A Global Scope. Children, 10.

3. Working group neonatal pharmacology (NeoDose project);Allegaert;Neonatology,2023